StockMacro
Menu

Privia Health

$25.05 +13% in 6 monthsMarket cap $3.2B

PRVA on XNAS, Health Care, Privia Health Group, Inc., job postings

Measures activity, not value. Not investment advice.

Revenue rose 19% to $2.4B over 12 months while net income rose 91% to $34.8M.

  • GoodLatest quarter revenue rose 13% to $657M
  • WatchNews: 24 articles in 7 days, 24.0 times its usual week

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Privia Health Group Inc is one of the physician enablement companies in the United States with a presence in around 24 states and the District of Columbia. The group builds scaled provider networks with primary-care centric medical groups, risk-bearing entities, a physician-led governance structure, and the Privia Platform comprising an extensive suite of technology and service solutions. It collaborates with medical groups, health plans, and health systems to optimize approximately 1,300+ physician practices, improve the patient experience for over 5.8+ million patients, and reward around 5,300+ physicians and practitioners for delivering high-value care.

Industry
Services-health services (Health Care)
Employees
1,226
Website
priviahealth.com
Listed
Nasdaq, US
Last results
5 Nov 2026
Next results
expected around 25 Feb 2027 (an estimate: a year ago it reported on 26 Feb 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $657.0M, net income $13.5M.
Quarter to 31 Dec 2021: revenue $275.3M, net income -$12.0MQuarter to 31 Dec 2021: revenue $275.3M, net income -$12.0MQuarter to 31 Mar 2022: revenue $313.8M, net income -$17.5MQuarter to 31 Mar 2022: revenue $313.8M, net income -$17.5MQuarter to 30 Jun 2022: revenue $335.5M, net income -$10.5MQuarter to 30 Jun 2022: revenue $335.5M, net income -$10.5MQuarter to 30 Sep 2022: revenue $342.9M, net income $1.6MQuarter to 30 Sep 2022: revenue $342.9M, net income $1.6MQuarter to 31 Dec 2022: revenue $364.4M, net income $17.8MQuarter to 31 Dec 2022: revenue $364.4M, net income $17.8MQuarter to 31 Mar 2023: revenue $386.3M, net income $7.3MQuarter to 31 Mar 2023: revenue $386.3M, net income $7.3MQuarter to 30 Jun 2023: revenue $413.4M, net income $7.3MQuarter to 30 Jun 2023: revenue $413.4M, net income $7.3MQuarter to 30 Sep 2023: revenue $417.3M, net income $5.6MQuarter to 30 Sep 2023: revenue $417.3M, net income $5.6MQuarter to 31 Dec 2023: revenue $440.8M, net income $2.8MQuarter to 31 Dec 2023: revenue $440.8M, net income $2.8MQuarter to 31 Mar 2024: revenue $415.2M, net income $3.0MQuarter to 31 Mar 2024: revenue $415.2M, net income $3.0MQuarter to 30 Jun 2024: revenue $422.3M, net income $3.5MQuarter to 30 Jun 2024: revenue $422.3M, net income $3.5MQuarter to 30 Sep 2024: revenue $437.9M, net income $3.5MQuarter to 30 Sep 2024: revenue $437.9M, net income $3.5MQuarter to 31 Dec 2024: revenue $460.9M, net income $4.4MQuarter to 31 Dec 2024: revenue $460.9M, net income $4.4MQuarter to 31 Mar 2025: revenue $480.1M, net income $4.2MQuarter to 31 Mar 2025: revenue $480.1M, net income $4.2MQuarter to 30 Jun 2025: revenue $521.2M, net income $2.7MQuarter to 30 Jun 2025: revenue $521.2M, net income $2.7MQuarter to 30 Sep 2025: revenue $580.4M, net income $6.9MQuarter to 30 Sep 2025: revenue $580.4M, net income $6.9MQuarter to 31 Dec 2025: revenue $541.2M, net income $9.2MQuarter to 31 Dec 2025: revenue $541.2M, net income $9.2MQuarter to 31 Mar 2026: revenue $603.8M, net income $3.1MQuarter to 31 Mar 2026: revenue $603.8M, net income $3.1MQuarter to 30 Jun 2026: revenue $632.6M, net income $9.0MQuarter to 30 Jun 2026: revenue $632.6M, net income $9.0MQuarter to 30 Sep 2026: revenue $657.0M, net income $13.5MQuarter to 30 Sep 2026: revenue $657.0M, net income $13.5M
31 Dec 2021RevenueNet incomeNet losstallest bar $657.0M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$657.0M$13.5M
30 Jun 2026$632.6M$9.0M
31 Mar 2026$603.8M$3.1M
31 Dec 2025$541.2M$9.2M
30 Sep 2025$580.4M$6.9M
30 Jun 2025$521.2M$2.7M
31 Mar 2025$480.1M$4.2M
31 Dec 2024$460.9M$4.4M
30 Sep 2024$437.9M$3.5M
30 Jun 2024$422.3M$3.5M
31 Mar 2024$415.2M$3.0M
31 Dec 2023$440.8M$2.8M
30 Sep 2023$417.3M$5.6M
30 Jun 2023$413.4M$7.3M
31 Mar 2023$386.3M$7.3M
31 Dec 2022$364.4M$17.8M
30 Sep 2022$342.9M$1.6M
30 Jun 2022$335.5M-$10.5M
31 Mar 2022$313.8M-$17.5M
31 Dec 2021$275.3M-$12.0M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $2.4B $2.0B
Revenue growthRevenue of the last 12 months compared with the 12 months before. +19% +15%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. $34.8M $18.2M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). $0.26 $0.13
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. – – 48.0%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. 2.1% 1.4% 1.7%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. 1.4% 0.9% 1.2%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. 4.6% 4.7%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. – –
CashCash, cash equivalents and short-term investments on the latest balance sheet. $446.3M $441.4M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. – –
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). – –
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. – 0.52
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $6.38
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. 92.1 62.8
P/SPrice to sales: market cap divided by revenue of the last 12 months. 1.3 1.7
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. – 1.6
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 3.9 3.3

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
Privia HealthPRVA (this company) $3.2B92.11.3+19%1.4%
LifeStance HealthLFST $5.3B73.13.1+23%4.3%
US Physical TherapyUSPH $1.4B47.51.7+10%3.6%
GeneDxWGS $1.4Bloss3.0+15%-24.1%
InnovAgeINNV $1.2B1391.2+15%0.9%
PennantPNTG $1.2B33.91.0+39%3.1%

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

–

No data for this company

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

-2.3%

291 13F filers vs 298

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

over 100%

129.2M shares held by 13F filers (30 Sep 2026) of 127.8M outstanding (30 Oct 2026); above 100%: the share count is probably stale

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

3.1%

3.9M shares sold short (30 Oct 2026) of 127.8M outstanding (30 Oct 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

4.5

3.9M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-22%

5.0M shares sold short in the report before, 3.9M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

43%

43% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 49%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

–

We do not track this company's careers site yet.

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

We do not track this company's careers site yet.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

–

No data for this company

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

+13%

$657.0M vs $580.4M (quarter ended 30 Sep 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

–

No data for this company

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

–

No data for this company

Lobbying What the company reported spending on federal lobbying over the last four quarters.

–

No data for this company

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

28

28 articles in the last 7 days; its usual week has 1 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

28×

28 articles in the last 7 days; its usual week has 1.

Price $25.05 on 20 Nov 2026, +11% over 12 months (12-month range $19.10 to $28.10)

  • Sharp change
  • 8-K and other filings
  • Lobbying filing
Insider net buying (open market). Insiders sold a net $22.2M in the last 12 months (the 12 months before: -$5.5M).
H-1B/E-3 applications certified. H-1B/E-3 applications certified: 1 published in the last 12 months (none in the 12 months before).
Revenue per quarter. Revenue $657.0M in the latest quarter, +13% on a year earlier.
Capital spending per quarter. Capital spending $23K in the latest quarter, +53% on a year earlier.
Institutional holders (13F filers). 291 13F filers reported holding it in the latest 13F quarter, +18% on a year earlier.
Lobbying spend. Lobbying spend: $0 published in the last 12 months.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: federal obligations, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
18 Aug 20268-K and other filingsDirector or officer change
7 Jul 20268-K and other filingsDirector or officer change
7 Jul 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
11 Nov 2025Sharp changeQuarterly revenue change: quarterly revenue change, 580.4M vs usual 439.4M (2025-09-30); 1.3x the same period a year earlier
8 Jul 20258-K and other filingsDirector or officer change
8 Jul 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
7 Mar 20258-K and other filingsDirector or officer change
7 Mar 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
3 Jul 20248-K and other filingsDirector or officer change
3 Jul 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
18 Apr 2024Lobbying filinglobbying engagement terminated (HEALTH POLICY SOURCE, INC.)
29 Jan 20248-K and other filingsDirector or officer change
29 Jan 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
14 Nov 2023Sharp changeShort interest spike: short interest spike, 6.6M vs usual 2.8M (2023-10-31); 2.3x the same period a year earlier
31 Oct 2023Sharp changeShort interest spike: short interest spike, 6.1M vs usual 2.8M (2023-10-13); 1.9x the same period a year earlier
17 Oct 2023Sharp changeShort interest spike: short interest spike, 6.4M vs usual 2.8M (2023-09-29); 2.0x the same period a year earlier
3 Oct 2023Sharp changeShort interest spike: short interest spike, 5.9M vs usual 2.7M (2023-09-15); 2.4x the same period a year earlier
19 Sep 2023Sharp changeShort interest spike: short interest spike, 6.2M vs usual 2.6M (2023-08-31); 3.0x the same period a year earlier
29 Aug 2023Sharp changeShort interest spike: short interest spike, 7.1M vs usual 2.6M (2023-08-15); 3.2x the same period a year earlier
15 Aug 2023Sharp changeMany funds opening a new position: many funds opening a new position, 61 vs usual 32 (2023-06-30); 2.0x the same period a year earlier
15 Aug 2023Sharp changeShort interest spike: short interest spike, 7.2M vs usual 2.5M (2023-07-31); 3.0x the same period a year earlier
1 Aug 2023Sharp changeShort interest spike: short interest spike, 7.6M vs usual 2.5M (2023-07-14); 3.8x the same period a year earlier
31 Jul 20238-K and other filingsDirector or officer change
18 Jul 2023Sharp changeShort interest spike: short interest spike, 7.4M vs usual 2.5M (2023-06-30); 3.0x the same period a year earlier
4 Jul 2023Sharp changeShort interest spike: short interest spike, 8.7M vs usual 2.4M (2023-06-15); 4.0x the same period a year earlier
29 Jun 20238-K and other filingsDirector or officer change
13 Jun 2023Sharp changeShort interest spike: short interest spike, 5.5M vs usual 2.4M (2023-05-31); 2.5x the same period a year earlier
30 May 2023Sharp changeShort interest spike: short interest spike, 5.7M vs usual 2.4M (2023-05-15); 2.8x the same period a year earlier
12 Apr 20238-K and other filingsDirector or officer change
12 Apr 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
21 Mar 20238-K and other filingsA major agreement ended
15 Nov 20228-K and other filingsDirector or officer change
15 Nov 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
16 Aug 2022Sharp changeQuarterly revenue change: quarterly revenue change, 335.5M vs usual 219.7M (2022-06-30); 1.5x the same period a year earlier
17 May 2022Sharp changeQuarterly revenue change: quarterly revenue change, 313.8M vs usual 213.7M (2022-03-31); 1.5x the same period a year earlier
31 Mar 20228-K and other filingsDirector or officer change
22 Mar 20228-K and other filingsDirector or officer change
6 Jan 20228-K and other filingsDirector or officer change
6 Jan 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
Insider net buying (open market)
Month from 1 Nov 2021: -$162.1M published
Month from 1 Dec 2021: -$1.4M published
Month from 1 Jan 2022: -$418K published
Month from 1 Feb 2022: -$891K published
Month from 1 Mar 2022: -$753K published
Month from 1 Apr 2022: -$838K published
Month from 1 Jun 2022: -$7.6M published
Month from 1 Jul 2022: -$21.1M published
Month from 1 Aug 2022: -$15.4M published
Month from 1 Sep 2022: -$56.5M published
Month from 1 Oct 2022: -$27.0M published
Month from 1 Nov 2022: -$137.8M published
Month from 1 Dec 2022: -$716K published
Month from 1 Jan 2023: -$1.2M published
Month from 1 Feb 2023: -$4.3M published
Month from 1 Mar 2023: -$10.5M published
Month from 1 Apr 2023: -$4.3M published
Month from 1 May 2023: -$927.5M published
Month from 1 Jun 2023: -$14.2M published
Month from 1 Jul 2023: -$1.7M published
Month from 1 Aug 2023: -$2.2M published
Month from 1 Sep 2023: -$1.3M published
Month from 1 Dec 2023: -$853K published
Month from 1 Jan 2024: -$507K published
Month from 1 Mar 2024: -$173K published
Month from 1 Apr 2024: -$70K published
Month from 1 May 2024: $8.4M published
Month from 1 Jun 2024: $94K published
Month from 1 Sep 2024: -$2.5M published
Month from 1 Feb 2025: -$2.5M published
Month from 1 Mar 2025: -$973K published
Month from 1 Apr 2025: -$126K published
Month from 1 May 2025: -$1.9M published
Month from 1 Dec 2025: -$939K published
Month from 1 Mar 2026: -$5.5M published
Month from 1 Apr 2026: -$116K published
Month from 1 May 2026: -$3.5M published
Month from 1 Jul 2026: -$12.2M published
H-1B/E-3 applications certified
Quarter from 1 Oct 2026: 1 published
Revenue per quarter
Quarter ended 31 Dec 2020: $213.7M; public on 26 Mar 2022
Quarter ended 31 Dec 2021: $275.3M, +29% on a year earlier; public on 26 Mar 2022
Quarter ended 31 Mar 2022: $313.8M, +47% on a year earlier; public on 13 May 2022
Quarter ended 30 Jun 2022: $335.5M, +49% on a year earlier; public on 12 Aug 2022
Quarter ended 30 Sep 2022: $342.9M, +36% on a year earlier; public on 11 Nov 2022
Quarter ended 31 Dec 2022: $364.4M, +32% on a year earlier; public on 2 Mar 2023
Quarter ended 31 Mar 2023: $386.3M, +23% on a year earlier; public on 5 May 2023
Quarter ended 30 Jun 2023: $413.4M, +23% on a year earlier; public on 4 Aug 2023
Quarter ended 30 Sep 2023: $417.3M, +22% on a year earlier; public on 4 Nov 2023
Quarter ended 31 Dec 2023: $440.8M, +21% on a year earlier; public on 28 Feb 2024
Quarter ended 31 Mar 2024: $415.2M, +7.5% on a year earlier; public on 10 May 2024
Quarter ended 30 Jun 2024: $422.3M, +2.2% on a year earlier; public on 9 Aug 2024
Quarter ended 30 Sep 2024: $437.9M, +4.9% on a year earlier; public on 8 Nov 2024
Quarter ended 31 Dec 2024: $460.9M, +4.6% on a year earlier; public on 28 Feb 2025
Quarter ended 31 Mar 2025: $480.1M, +16% on a year earlier; public on 9 May 2025
Quarter ended 30 Jun 2025: $521.2M, +23% on a year earlier; public on 8 Aug 2025
Quarter ended 30 Sep 2025: $580.4M, +33% on a year earlier; public on 7 Nov 2025
Quarter ended 31 Dec 2025: $541.2M, +17% on a year earlier; public on 28 Feb 2026
Quarter ended 31 Mar 2026: $603.8M, +26% on a year earlier; public on 8 May 2026
Quarter ended 30 Jun 2026: $632.6M, +21% on a year earlier; public on 7 Aug 2026
Quarter ended 30 Sep 2026: $657.0M, +13% on a year earlier; public on 6 Nov 2026
Capital spending per quarter
Quarter ended 31 Dec 2020: $0; public on 26 Mar 2022
Quarter ended 31 Dec 2021: $151K; public on 26 Mar 2022
Quarter ended 31 Mar 2022: $34K; public on 13 May 2022
Quarter ended 30 Jun 2022: $39K, -80% on a year earlier; public on 12 Aug 2022
Quarter ended 30 Sep 2022: $16K, -92% on a year earlier; public on 11 Nov 2022
Quarter ended 31 Dec 2022: $15K, -90% on a year earlier; public on 2 Mar 2023
Quarter ended 31 Mar 2023: $0, -100% on a year earlier; public on 5 May 2023
Quarter ended 30 Jun 2023: $72K, +85% on a year earlier; public on 4 Aug 2023
Quarter ended 30 Sep 2023: $18K, +12% on a year earlier; public on 4 Nov 2023
Quarter ended 31 Dec 2023: $23K, +53% on a year earlier; public on 28 Feb 2024
Institutional holders (13F filers)
31 Dec 2021 report: 112; public on 14 Feb 2022
31 Mar 2022 report: 142; public on 16 May 2022
30 Jun 2022 report: 143; public on 15 Aug 2022
30 Sep 2022 report: 186; public on 14 Nov 2022
31 Dec 2022 report: 185; public on 14 Feb 2023
31 Mar 2023 report: 185; public on 15 May 2023
30 Jun 2023 report: 220; public on 14 Aug 2023
30 Sep 2023 report: 206; public on 14 Nov 2023
31 Dec 2023 report: 213; public on 14 Feb 2024
31 Mar 2024 report: 223; public on 15 May 2024
30 Jun 2024 report: 212; public on 14 Aug 2024
30 Sep 2024 report: 224; public on 14 Nov 2024
31 Dec 2024 report: 225; public on 14 Feb 2025
31 Mar 2025 report: 239; public on 15 May 2025
30 Jun 2025 report: 271; public on 14 Aug 2025
30 Sep 2025 report: 247; public on 14 Nov 2025
31 Dec 2025 report: 264; public on 17 Feb 2026
31 Mar 2026 report: 284; public on 15 May 2026
30 Jun 2026 report: 298; public on 14 Aug 2026
30 Sep 2026 report: 291; public on 16 Nov 2026
Lobbying spend
Quarter from 1 Jan 2022: $20K published
Quarter from 1 Apr 2022: $10K published
Quarter from 1 Jul 2022: $20K published
Quarter from 1 Oct 2022: $20K published
Quarter from 1 Jan 2023: $20K published
Quarter from 1 Apr 2023: $20K published
Quarter from 1 Jul 2023: $20K published
Quarter from 1 Oct 2023: $20K published
Quarter from 1 Jan 2024: $10K published
Quarter from 1 Apr 2024: $10K published

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is 13F holders (funds reporting the stock) at 291 (30 Sep 2026), 1.3× its normal reading; higher than 95% of its own history.
  • Insider net buying (open market): Insiders sold a net $22.2M in the last 12 months (the 12 months before: -$5.5M).
  • H-1B/E-3 applications certified: H-1B/E-3 applications certified: 1 published in the last 12 months (none in the 12 months before).
  • Revenue per quarter: Revenue $657.0M in the latest quarter, +13% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

No trades in the last 90 days; the latest was filed 13 Jul 2026. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
13 Jul 2026David MountcastleEVP & Chief Financial OfficerSellplanned in advance (10b5-1)21,275$27.67$589KForm 4
9 Jul 2026David MountcastleEVP & Chief Financial OfficerSellplanned in advance (10b5-1)600$27.57$17KForm 4
7 Jul 2026Matthew Shawn MorrisDirectorSellplanned in advance (10b5-1); after exercising options112,759$27.29$3.1MForm 4
7 Jul 2026David MountcastleEVP & Chief Financial OfficerSellplanned in advance (10b5-1)24,734$27.50$680KForm 4
2 Jul 2026Matthew Shawn MorrisDirectorSellplanned in advance (10b5-1); after exercising options135,498$26.32$3.6MForm 4
30 Jun 2026Matthew Shawn MorrisDirectorSellplanned in advance (10b5-1); after exercising options151,322$25.33$3.8MForm 4
30 Jun 2026David MountcastleEVP & Chief Financial OfficerSellplanned in advance (10b5-1); after exercising options17,196$25.18$433KForm 4
13 May 2026Parth MehrotraChief Executive OfficerSellplanned in advance (10b5-1)121,086$22.56$2.7MForm 4

291 institutions reported shares at the end of Q3 2026, 100% of the shares outstanding; 41 opened a position, 49 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
BlackRock, Inc.22.7M17.7%$446.0M+1.2M+5.8%
Durable Capital Partners LP12.0M9.37%$235.7M+335K+2.9%
FMR LLC (Fidelity)6.8M5.35%$134.5M-6.0M-47%
Vanguard Portfolio Management LLC6.8M5.32%$133.8M+222K+3.4%
Rubicon Founders LLC6.5M5.07%$127.4M+501K+8.4%
Vanguard Capital Management LLC5.5M4.34%$109.1M+386K+7.5%
State Street Corp5.1M4.03%$101.3M+239K+4.9%
Van Berkom & Associates Inc.3.7M2.88%-26K-0.7%
Wellington Management Group LLP3.5M2.75%$69.3M+1.4M+65%
Geode Capital Management, LLC3.2M2.51%$63.1M+73K+2.3%

Company events

All 26 company events

In 12 months: 2 director or officer changes. Results releases and routine reports are left out.

FiledWhat happenedSource
18 Aug 2026Director or officer change8-K
7 Jul 2026Director or officer change8-K
8 Jul 2025Director or officer change8-K
7 Mar 2025Director or officer change8-K
3 Jul 2024Director or officer change8-K
29 Jan 2024Director or officer change8-K
21 Nov 2023Signed a major agreement8-K
31 Jul 2023Director or officer changeSame filing: changed its bylaws or fiscal year8-K

Reported lobbying spend: $10K in Q1 2024, $10K in Q4 2023. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.

DateChangeLobbying firmIssueSource
25 Jan 2024EndedHealth Policy Source, Inc.for Privia Medical Group - North TexasAll matters pertaining to Federal healthcare programs in the legislative and regulatory arenas.Medicare/MedicaidFiling
1 Apr 2020NewHealth Policy Source, Inc.for Privia Medical Group - North TexasFederal COVID-19 relief and related federal healthcare programming.Medicare/MedicaidFiling

The 5 newest of 121 articles that name the company.

Timeline

Several things at once

Two or more unrelated kinds of records unusual within 30 days

15 Aug 2023confirmed

Confirmed across sources Institutional holdings and Short interest and volume

Privia Health (PRVA): saw 61 13F filers open a new position in the quarter ended 30 Jun 2023, 2.0× the same quarter last year, while it had 7.1M shares sold short in the 15 Aug 2023 report, 3.2× the same report last year. Two unrelated kinds of activity within 119 days.

  • Short interest and volume: Short interest spike, became public on 13 Jul 2023
  • Short interest and volume: Short interest spike, became public on 26 Jul 2023
  • Institutional holdings: Many funds opening a new position, became public on 14 Aug 2023
  • Short interest and volume: Short interest spike, became public on 10 Aug 2023
  • Short interest and volume: Short interest spike, became public on 25 Aug 2023
  • Short interest and volume: Short interest spike, became public on 13 Sep 2023
  • Short interest and volume: Short interest spike, became public on 27 Sep 2023
  • Short interest and volume: Short interest spike, became public on 12 Oct 2023
  • Short interest and volume: Short interest spike, became public on 25 Oct 2023
  • Short interest and volume: Short interest spike, became public on 10 Nov 2023
2021-06-30: 852021-09-30: 202021-12-31: 332022-03-31: 392022-06-30: 302022-09-30: 622022-12-31: 302023-03-31: 312023-06-30: 61
The quarter ended 30 Jun 2023 against the 8 quarters before it. this quarterearliernormal: 32
See the evidence (10 changes)

Short interest and volume: Short interest spike became public on 13 Jul 2023

Privia Health had 7.4M shares sold short in the 30 Jun 2023 report, 3.0× the same report last year.

This period
7.4M (the 30 Jun 2023 report)
Normal report (median of 24 earlier)
2.5M
Typical spread (median absolute deviation)
250K
How far from its usual level
+13.2
Same report last year
2.5M
History used
777 days
2022-06-30: 2.5M2022-07-15: 2.0M2022-07-29: 2.4M2022-08-15: 2.2M2022-08-31: 2.1M2022-09-15: 2.5M2022-09-30: 3.1M2022-10-14: 3.2M2022-10-31: 2.8M2022-11-15: 2.4M2022-11-30: 2.6M2022-12-15: 2.4M2022-12-30: 2.5M2023-01-13: 2.7M2023-01-31: 2.3M2023-02-15: 2.5M2023-02-28: 2.6M2023-03-15: 2.2M2023-03-31: 2.1M2023-04-14: 2.2M2023-04-28: 2.0M2023-05-15: 5.7M2023-05-31: 5.5M2023-06-15: 8.7M2023-06-30: 7.4M
the 30 Jun 2023 report24 earlier reportsnormal: 2.5M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 26 Jul 2023

Privia Health had 7.6M shares sold short in the 14 Jul 2023 report, 3.8× the same report last year.

This period
7.6M (the 14 Jul 2023 report)
Normal report (median of 24 earlier)
2.5M
Typical spread (median absolute deviation)
261K
How far from its usual level
+13.3
Same report last year
2.0M
History used
791 days
2022-07-15: 2.0M2022-07-29: 2.4M2022-08-15: 2.2M2022-08-31: 2.1M2022-09-15: 2.5M2022-09-30: 3.1M2022-10-14: 3.2M2022-10-31: 2.8M2022-11-15: 2.4M2022-11-30: 2.6M2022-12-15: 2.4M2022-12-30: 2.5M2023-01-13: 2.7M2023-01-31: 2.3M2023-02-15: 2.5M2023-02-28: 2.6M2023-03-15: 2.2M2023-03-31: 2.1M2023-04-14: 2.2M2023-04-28: 2.0M2023-05-15: 5.7M2023-05-31: 5.5M2023-06-15: 8.7M2023-06-30: 7.4M2023-07-14: 7.6M
the 14 Jul 2023 report24 earlier reportsnormal: 2.5M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Institutional holdings: Many funds opening a new position became public on 14 Aug 2023

Privia Health saw 61 13F filers open a new position in the quarter ended 30 Jun 2023, 2.0× the same quarter last year.

This period
61 (the quarter ended 30 Jun 2023)
Normal quarter (median of 8 earlier)
32
Typical spread (median absolute deviation)
4.5
How far from its usual level
+4.3
Same quarter last year
30
History used
730 days
2021-06-30: 852021-09-30: 202021-12-31: 332022-03-31: 392022-06-30: 302022-09-30: 622022-12-31: 302023-03-31: 312023-06-30: 61
the quarter ended 30 Jun 20238 earlier quartersnormal: 32

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

Check it at the source: SEC Form 13F data sets.

Short interest and volume: Short interest spike became public on 10 Aug 2023

Privia Health had 7.2M shares sold short in the 31 Jul 2023 report, 3.0× the same report last year.

This period
7.2M (the 31 Jul 2023 report)
Normal report (median of 24 earlier)
2.5M
Typical spread (median absolute deviation)
299K
How far from its usual level
+10.6
Same report last year
2.4M
History used
808 days
2022-07-29: 2.4M2022-08-15: 2.2M2022-08-31: 2.1M2022-09-15: 2.5M2022-09-30: 3.1M2022-10-14: 3.2M2022-10-31: 2.8M2022-11-15: 2.4M2022-11-30: 2.6M2022-12-15: 2.4M2022-12-30: 2.5M2023-01-13: 2.7M2023-01-31: 2.3M2023-02-15: 2.5M2023-02-28: 2.6M2023-03-15: 2.2M2023-03-31: 2.1M2023-04-14: 2.2M2023-04-28: 2.0M2023-05-15: 5.7M2023-05-31: 5.5M2023-06-15: 8.7M2023-06-30: 7.4M2023-07-14: 7.6M2023-07-31: 7.2M
the 31 Jul 2023 report24 earlier reportsnormal: 2.5M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 25 Aug 2023

Privia Health had 7.1M shares sold short in the 15 Aug 2023 report, 3.2× the same report last year.

This period
7.1M (the 15 Aug 2023 report)
Normal report (median of 24 earlier)
2.6M
Typical spread (median absolute deviation)
377K
How far from its usual level
+8.2
Same report last year
2.2M
History used
823 days
2022-08-15: 2.2M2022-08-31: 2.1M2022-09-15: 2.5M2022-09-30: 3.1M2022-10-14: 3.2M2022-10-31: 2.8M2022-11-15: 2.4M2022-11-30: 2.6M2022-12-15: 2.4M2022-12-30: 2.5M2023-01-13: 2.7M2023-01-31: 2.3M2023-02-15: 2.5M2023-02-28: 2.6M2023-03-15: 2.2M2023-03-31: 2.1M2023-04-14: 2.2M2023-04-28: 2.0M2023-05-15: 5.7M2023-05-31: 5.5M2023-06-15: 8.7M2023-06-30: 7.4M2023-07-14: 7.6M2023-07-31: 7.2M2023-08-15: 7.1M
the 15 Aug 2023 report24 earlier reportsnormal: 2.6M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 13 Sep 2023

Privia Health had 6.2M shares sold short in the 31 Aug 2023 report, 3.0× the same report last year.

This period
6.2M (the 31 Aug 2023 report)
Normal report (median of 24 earlier)
2.6M
Typical spread (median absolute deviation)
448K
How far from its usual level
+5.4
Same report last year
2.1M
History used
839 days
2022-08-31: 2.1M2022-09-15: 2.5M2022-09-30: 3.1M2022-10-14: 3.2M2022-10-31: 2.8M2022-11-15: 2.4M2022-11-30: 2.6M2022-12-15: 2.4M2022-12-30: 2.5M2023-01-13: 2.7M2023-01-31: 2.3M2023-02-15: 2.5M2023-02-28: 2.6M2023-03-15: 2.2M2023-03-31: 2.1M2023-04-14: 2.2M2023-04-28: 2.0M2023-05-15: 5.7M2023-05-31: 5.5M2023-06-15: 8.7M2023-06-30: 7.4M2023-07-14: 7.6M2023-07-31: 7.2M2023-08-15: 7.1M2023-08-31: 6.2M
the 31 Aug 2023 report24 earlier reportsnormal: 2.6M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 27 Sep 2023

Privia Health had 5.9M shares sold short in the 15 Sep 2023 report, 2.4× the same report last year.

This period
5.9M (the 15 Sep 2023 report)
Normal report (median of 24 earlier)
2.7M
Typical spread (median absolute deviation)
477K
How far from its usual level
+4.6
Same report last year
2.5M
History used
854 days
2022-09-15: 2.5M2022-09-30: 3.1M2022-10-14: 3.2M2022-10-31: 2.8M2022-11-15: 2.4M2022-11-30: 2.6M2022-12-15: 2.4M2022-12-30: 2.5M2023-01-13: 2.7M2023-01-31: 2.3M2023-02-15: 2.5M2023-02-28: 2.6M2023-03-15: 2.2M2023-03-31: 2.1M2023-04-14: 2.2M2023-04-28: 2.0M2023-05-15: 5.7M2023-05-31: 5.5M2023-06-15: 8.7M2023-06-30: 7.4M2023-07-14: 7.6M2023-07-31: 7.2M2023-08-15: 7.1M2023-08-31: 6.2M2023-09-15: 5.9M
the 15 Sep 2023 report24 earlier reportsnormal: 2.7M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 12 Oct 2023

Privia Health had 6.4M shares sold short in the 29 Sep 2023 report, 2.0× the same report last year.

This period
6.4M (the 29 Sep 2023 report)
Normal report (median of 24 earlier)
2.8M
Typical spread (median absolute deviation)
569K
How far from its usual level
+4.3
Same report last year
3.1M
History used
868 days
2022-09-30: 3.1M2022-10-14: 3.2M2022-10-31: 2.8M2022-11-15: 2.4M2022-11-30: 2.6M2022-12-15: 2.4M2022-12-30: 2.5M2023-01-13: 2.7M2023-01-31: 2.3M2023-02-15: 2.5M2023-02-28: 2.6M2023-03-15: 2.2M2023-03-31: 2.1M2023-04-14: 2.2M2023-04-28: 2.0M2023-05-15: 5.7M2023-05-31: 5.5M2023-06-15: 8.7M2023-06-30: 7.4M2023-07-14: 7.6M2023-07-31: 7.2M2023-08-15: 7.1M2023-08-31: 6.2M2023-09-15: 5.9M2023-09-29: 6.4M
the 29 Sep 2023 report24 earlier reportsnormal: 2.8M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 25 Oct 2023

Privia Health had 6.1M shares sold short in the 13 Oct 2023 report, 1.9× the same report last year.

This period
6.1M (the 13 Oct 2023 report)
Normal report (median of 24 earlier)
2.8M
Typical spread (median absolute deviation)
592K
How far from its usual level
+3.8
Same report last year
3.2M
History used
882 days
2022-10-14: 3.2M2022-10-31: 2.8M2022-11-15: 2.4M2022-11-30: 2.6M2022-12-15: 2.4M2022-12-30: 2.5M2023-01-13: 2.7M2023-01-31: 2.3M2023-02-15: 2.5M2023-02-28: 2.6M2023-03-15: 2.2M2023-03-31: 2.1M2023-04-14: 2.2M2023-04-28: 2.0M2023-05-15: 5.7M2023-05-31: 5.5M2023-06-15: 8.7M2023-06-30: 7.4M2023-07-14: 7.6M2023-07-31: 7.2M2023-08-15: 7.1M2023-08-31: 6.2M2023-09-15: 5.9M2023-09-29: 6.4M2023-10-13: 6.1M
the 13 Oct 2023 report24 earlier reportsnormal: 2.8M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 10 Nov 2023

Privia Health had 6.6M shares sold short in the 31 Oct 2023 report, 2.3× the same report last year.

This period
6.6M (the 31 Oct 2023 report)
Normal report (median of 24 earlier)
2.8M
Typical spread (median absolute deviation)
698K
How far from its usual level
+3.7
Same report last year
2.8M
History used
900 days
2022-10-31: 2.8M2022-11-15: 2.4M2022-11-30: 2.6M2022-12-15: 2.4M2022-12-30: 2.5M2023-01-13: 2.7M2023-01-31: 2.3M2023-02-15: 2.5M2023-02-28: 2.6M2023-03-15: 2.2M2023-03-31: 2.1M2023-04-14: 2.2M2023-04-28: 2.0M2023-05-15: 5.7M2023-05-31: 5.5M2023-06-15: 8.7M2023-06-30: 7.4M2023-07-14: 7.6M2023-07-31: 7.2M2023-08-15: 7.1M2023-08-31: 6.2M2023-09-15: 5.9M2023-09-29: 6.4M2023-10-13: 6.1M2023-10-31: 6.6M
the 31 Oct 2023 report24 earlier reportsnormal: 2.8M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

Timeline

Changes and notable records, by the date each became public

  1. 18 Aug 2026Filings record

    Director or officer change

  2. 7 Jul 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  3. 7 Jul 2026Filings record

    Director or officer change

  4. 11 Nov 2025Financials change

    reported revenue of $580.4M for the quarter ended 30 Sep 2025, 1.3× the same quarter last year.

    Same quarter last year: $437.9M; its normal quarter is $439.4M.

    See the evidence
    This period
    $580.4M (the quarter ended 30 Sep 2025)
    Normal quarter (median of 8 earlier)
    $439.4M
    Typical spread (median absolute deviation)
    $21.8M
    How far from its usual level
    +3.2
    Same quarter last year
    $437.9M
    History used
    2,009 days
    2023-09-30: $417.3M2023-12-31: $440.8M2024-03-31: $415.2M2024-06-30: $422.3M2024-09-30: $437.9M2024-12-31: $460.9M2025-03-31: $480.1M2025-06-30: $521.2M2025-09-30: $580.4M
    the quarter ended 30 Sep 20258 earlier quartersnormal: $439.4M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  5. 8 Jul 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  6. 8 Jul 2025Filings record

    Director or officer change

  7. 7 Mar 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  8. 7 Mar 2025Filings record

    Director or officer change

  9. 3 Jul 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  10. 3 Jul 2024Filings record

    Director or officer change

  11. 14 Jun 2024Insiders record

    Boehler Adam (director) bought 364 shares of PRVA ($6,006) (dated 13 Jun 2024)

  12. 1 Jun 2024Insiders record

    Boehler Adam (director) bought 5,306 shares of PRVA ($87,549) (dated 31 May 2024)

  13. 30 May 2024Insiders record

    Boehler Adam (director) bought 4,280 shares of PRVA ($70,577) (dated 29 May 2024)

  14. 24 May 2024Insiders record

    McCarthy Thomas A (director) bought 10,000 shares of PRVA ($163,700) (dated 23 May 2024)

  15. 24 May 2024Insiders record

    Boehler Adam (director) bought 552,436 shares of PRVA ($9.0M) (dated 23 May 2024)

  16. 18 Apr 2024Lobbying record

    PRIVIA MEDICAL GROUP - NORTH TEXAS: lobbying engagement terminated (HEALTH POLICY SOURCE, INC.) (dated 25 Jan 2024)

  17. 29 Jan 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  18. 29 Jan 2024Filings record

    Director or officer change

  19. 10 Nov 2023Short interest and volume change

    had 6.6M shares sold short in the 31 Oct 2023 report, 2.3× the same report last year.

    Same report last year: 2.8M; its normal report is 2.8M.

    See the evidence
    This period
    6.6M (the 31 Oct 2023 report)
    Normal report (median of 24 earlier)
    2.8M
    Typical spread (median absolute deviation)
    698K
    How far from its usual level
    +3.7
    Same report last year
    2.8M
    History used
    900 days
    2022-10-31: 2.8M2022-11-15: 2.4M2022-11-30: 2.6M2022-12-15: 2.4M2022-12-30: 2.5M2023-01-13: 2.7M2023-01-31: 2.3M2023-02-15: 2.5M2023-02-28: 2.6M2023-03-15: 2.2M2023-03-31: 2.1M2023-04-14: 2.2M2023-04-28: 2.0M2023-05-15: 5.7M2023-05-31: 5.5M2023-06-15: 8.7M2023-06-30: 7.4M2023-07-14: 7.6M2023-07-31: 7.2M2023-08-15: 7.1M2023-08-31: 6.2M2023-09-15: 5.9M2023-09-29: 6.4M2023-10-13: 6.1M2023-10-31: 6.6M
    the 31 Oct 2023 report24 earlier reportsnormal: 2.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  20. 25 Oct 2023Short interest and volume change

    had 6.1M shares sold short in the 13 Oct 2023 report, 1.9× the same report last year.

    Same report last year: 3.2M; its normal report is 2.8M.

    See the evidence
    This period
    6.1M (the 13 Oct 2023 report)
    Normal report (median of 24 earlier)
    2.8M
    Typical spread (median absolute deviation)
    592K
    How far from its usual level
    +3.8
    Same report last year
    3.2M
    History used
    882 days
    2022-10-14: 3.2M2022-10-31: 2.8M2022-11-15: 2.4M2022-11-30: 2.6M2022-12-15: 2.4M2022-12-30: 2.5M2023-01-13: 2.7M2023-01-31: 2.3M2023-02-15: 2.5M2023-02-28: 2.6M2023-03-15: 2.2M2023-03-31: 2.1M2023-04-14: 2.2M2023-04-28: 2.0M2023-05-15: 5.7M2023-05-31: 5.5M2023-06-15: 8.7M2023-06-30: 7.4M2023-07-14: 7.6M2023-07-31: 7.2M2023-08-15: 7.1M2023-08-31: 6.2M2023-09-15: 5.9M2023-09-29: 6.4M2023-10-13: 6.1M
    the 13 Oct 2023 report24 earlier reportsnormal: 2.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  21. 12 Oct 2023Short interest and volume change

    had 6.4M shares sold short in the 29 Sep 2023 report, 2.0× the same report last year.

    Same report last year: 3.1M; its normal report is 2.8M.

    See the evidence
    This period
    6.4M (the 29 Sep 2023 report)
    Normal report (median of 24 earlier)
    2.8M
    Typical spread (median absolute deviation)
    569K
    How far from its usual level
    +4.3
    Same report last year
    3.1M
    History used
    868 days
    2022-09-30: 3.1M2022-10-14: 3.2M2022-10-31: 2.8M2022-11-15: 2.4M2022-11-30: 2.6M2022-12-15: 2.4M2022-12-30: 2.5M2023-01-13: 2.7M2023-01-31: 2.3M2023-02-15: 2.5M2023-02-28: 2.6M2023-03-15: 2.2M2023-03-31: 2.1M2023-04-14: 2.2M2023-04-28: 2.0M2023-05-15: 5.7M2023-05-31: 5.5M2023-06-15: 8.7M2023-06-30: 7.4M2023-07-14: 7.6M2023-07-31: 7.2M2023-08-15: 7.1M2023-08-31: 6.2M2023-09-15: 5.9M2023-09-29: 6.4M
    the 29 Sep 2023 report24 earlier reportsnormal: 2.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  22. 27 Sep 2023Short interest and volume change

    had 5.9M shares sold short in the 15 Sep 2023 report, 2.4× the same report last year.

    Same report last year: 2.5M; its normal report is 2.7M.

    See the evidence
    This period
    5.9M (the 15 Sep 2023 report)
    Normal report (median of 24 earlier)
    2.7M
    Typical spread (median absolute deviation)
    477K
    How far from its usual level
    +4.6
    Same report last year
    2.5M
    History used
    854 days
    2022-09-15: 2.5M2022-09-30: 3.1M2022-10-14: 3.2M2022-10-31: 2.8M2022-11-15: 2.4M2022-11-30: 2.6M2022-12-15: 2.4M2022-12-30: 2.5M2023-01-13: 2.7M2023-01-31: 2.3M2023-02-15: 2.5M2023-02-28: 2.6M2023-03-15: 2.2M2023-03-31: 2.1M2023-04-14: 2.2M2023-04-28: 2.0M2023-05-15: 5.7M2023-05-31: 5.5M2023-06-15: 8.7M2023-06-30: 7.4M2023-07-14: 7.6M2023-07-31: 7.2M2023-08-15: 7.1M2023-08-31: 6.2M2023-09-15: 5.9M
    the 15 Sep 2023 report24 earlier reportsnormal: 2.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  23. 13 Sep 2023Short interest and volume change

    had 6.2M shares sold short in the 31 Aug 2023 report, 3.0× the same report last year.

    Same report last year: 2.1M; its normal report is 2.6M.

    See the evidence
    This period
    6.2M (the 31 Aug 2023 report)
    Normal report (median of 24 earlier)
    2.6M
    Typical spread (median absolute deviation)
    448K
    How far from its usual level
    +5.4
    Same report last year
    2.1M
    History used
    839 days
    2022-08-31: 2.1M2022-09-15: 2.5M2022-09-30: 3.1M2022-10-14: 3.2M2022-10-31: 2.8M2022-11-15: 2.4M2022-11-30: 2.6M2022-12-15: 2.4M2022-12-30: 2.5M2023-01-13: 2.7M2023-01-31: 2.3M2023-02-15: 2.5M2023-02-28: 2.6M2023-03-15: 2.2M2023-03-31: 2.1M2023-04-14: 2.2M2023-04-28: 2.0M2023-05-15: 5.7M2023-05-31: 5.5M2023-06-15: 8.7M2023-06-30: 7.4M2023-07-14: 7.6M2023-07-31: 7.2M2023-08-15: 7.1M2023-08-31: 6.2M
    the 31 Aug 2023 report24 earlier reportsnormal: 2.6M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  24. 25 Aug 2023Short interest and volume change

    had 7.1M shares sold short in the 15 Aug 2023 report, 3.2× the same report last year.

    Same report last year: 2.2M; its normal report is 2.6M.

    See the evidence
    This period
    7.1M (the 15 Aug 2023 report)
    Normal report (median of 24 earlier)
    2.6M
    Typical spread (median absolute deviation)
    377K
    How far from its usual level
    +8.2
    Same report last year
    2.2M
    History used
    823 days
    2022-08-15: 2.2M2022-08-31: 2.1M2022-09-15: 2.5M2022-09-30: 3.1M2022-10-14: 3.2M2022-10-31: 2.8M2022-11-15: 2.4M2022-11-30: 2.6M2022-12-15: 2.4M2022-12-30: 2.5M2023-01-13: 2.7M2023-01-31: 2.3M2023-02-15: 2.5M2023-02-28: 2.6M2023-03-15: 2.2M2023-03-31: 2.1M2023-04-14: 2.2M2023-04-28: 2.0M2023-05-15: 5.7M2023-05-31: 5.5M2023-06-15: 8.7M2023-06-30: 7.4M2023-07-14: 7.6M2023-07-31: 7.2M2023-08-15: 7.1M
    the 15 Aug 2023 report24 earlier reportsnormal: 2.6M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  25. 15 Aug 2023several at once

    saw 61 13F filers open a new position in the quarter ended 30 Jun 2023, 2.0× the same quarter last year, while it had 7.1M shares sold short in the 15 Aug 2023 report, 3.2× the same report last year. Two unrelated kinds of activity within 119 days.

    See the evidence (10 changes)

    Short interest and volume: Short interest spike became public on 13 Jul 2023

    Privia Health had 7.4M shares sold short in the 30 Jun 2023 report, 3.0× the same report last year.

    This period
    7.4M (the 30 Jun 2023 report)
    Normal report (median of 24 earlier)
    2.5M
    Typical spread (median absolute deviation)
    250K
    How far from its usual level
    +13.2
    Same report last year
    2.5M
    History used
    777 days
    2022-06-30: 2.5M2022-07-15: 2.0M2022-07-29: 2.4M2022-08-15: 2.2M2022-08-31: 2.1M2022-09-15: 2.5M2022-09-30: 3.1M2022-10-14: 3.2M2022-10-31: 2.8M2022-11-15: 2.4M2022-11-30: 2.6M2022-12-15: 2.4M2022-12-30: 2.5M2023-01-13: 2.7M2023-01-31: 2.3M2023-02-15: 2.5M2023-02-28: 2.6M2023-03-15: 2.2M2023-03-31: 2.1M2023-04-14: 2.2M2023-04-28: 2.0M2023-05-15: 5.7M2023-05-31: 5.5M2023-06-15: 8.7M2023-06-30: 7.4M
    the 30 Jun 2023 report24 earlier reportsnormal: 2.5M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 26 Jul 2023

    Privia Health had 7.6M shares sold short in the 14 Jul 2023 report, 3.8× the same report last year.

    This period
    7.6M (the 14 Jul 2023 report)
    Normal report (median of 24 earlier)
    2.5M
    Typical spread (median absolute deviation)
    261K
    How far from its usual level
    +13.3
    Same report last year
    2.0M
    History used
    791 days
    2022-07-15: 2.0M2022-07-29: 2.4M2022-08-15: 2.2M2022-08-31: 2.1M2022-09-15: 2.5M2022-09-30: 3.1M2022-10-14: 3.2M2022-10-31: 2.8M2022-11-15: 2.4M2022-11-30: 2.6M2022-12-15: 2.4M2022-12-30: 2.5M2023-01-13: 2.7M2023-01-31: 2.3M2023-02-15: 2.5M2023-02-28: 2.6M2023-03-15: 2.2M2023-03-31: 2.1M2023-04-14: 2.2M2023-04-28: 2.0M2023-05-15: 5.7M2023-05-31: 5.5M2023-06-15: 8.7M2023-06-30: 7.4M2023-07-14: 7.6M
    the 14 Jul 2023 report24 earlier reportsnormal: 2.5M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Institutional holdings: Many funds opening a new position became public on 14 Aug 2023

    Privia Health saw 61 13F filers open a new position in the quarter ended 30 Jun 2023, 2.0× the same quarter last year.

    This period
    61 (the quarter ended 30 Jun 2023)
    Normal quarter (median of 8 earlier)
    32
    Typical spread (median absolute deviation)
    4.5
    How far from its usual level
    +4.3
    Same quarter last year
    30
    History used
    730 days
    2021-06-30: 852021-09-30: 202021-12-31: 332022-03-31: 392022-06-30: 302022-09-30: 622022-12-31: 302023-03-31: 312023-06-30: 61
    the quarter ended 30 Jun 20238 earlier quartersnormal: 32

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

    Short interest and volume: Short interest spike became public on 10 Aug 2023

    Privia Health had 7.2M shares sold short in the 31 Jul 2023 report, 3.0× the same report last year.

    This period
    7.2M (the 31 Jul 2023 report)
    Normal report (median of 24 earlier)
    2.5M
    Typical spread (median absolute deviation)
    299K
    How far from its usual level
    +10.6
    Same report last year
    2.4M
    History used
    808 days
    2022-07-29: 2.4M2022-08-15: 2.2M2022-08-31: 2.1M2022-09-15: 2.5M2022-09-30: 3.1M2022-10-14: 3.2M2022-10-31: 2.8M2022-11-15: 2.4M2022-11-30: 2.6M2022-12-15: 2.4M2022-12-30: 2.5M2023-01-13: 2.7M2023-01-31: 2.3M2023-02-15: 2.5M2023-02-28: 2.6M2023-03-15: 2.2M2023-03-31: 2.1M2023-04-14: 2.2M2023-04-28: 2.0M2023-05-15: 5.7M2023-05-31: 5.5M2023-06-15: 8.7M2023-06-30: 7.4M2023-07-14: 7.6M2023-07-31: 7.2M
    the 31 Jul 2023 report24 earlier reportsnormal: 2.5M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 25 Aug 2023

    Privia Health had 7.1M shares sold short in the 15 Aug 2023 report, 3.2× the same report last year.

    This period
    7.1M (the 15 Aug 2023 report)
    Normal report (median of 24 earlier)
    2.6M
    Typical spread (median absolute deviation)
    377K
    How far from its usual level
    +8.2
    Same report last year
    2.2M
    History used
    823 days
    2022-08-15: 2.2M2022-08-31: 2.1M2022-09-15: 2.5M2022-09-30: 3.1M2022-10-14: 3.2M2022-10-31: 2.8M2022-11-15: 2.4M2022-11-30: 2.6M2022-12-15: 2.4M2022-12-30: 2.5M2023-01-13: 2.7M2023-01-31: 2.3M2023-02-15: 2.5M2023-02-28: 2.6M2023-03-15: 2.2M2023-03-31: 2.1M2023-04-14: 2.2M2023-04-28: 2.0M2023-05-15: 5.7M2023-05-31: 5.5M2023-06-15: 8.7M2023-06-30: 7.4M2023-07-14: 7.6M2023-07-31: 7.2M2023-08-15: 7.1M
    the 15 Aug 2023 report24 earlier reportsnormal: 2.6M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 13 Sep 2023

    Privia Health had 6.2M shares sold short in the 31 Aug 2023 report, 3.0× the same report last year.

    This period
    6.2M (the 31 Aug 2023 report)
    Normal report (median of 24 earlier)
    2.6M
    Typical spread (median absolute deviation)
    448K
    How far from its usual level
    +5.4
    Same report last year
    2.1M
    History used
    839 days
    2022-08-31: 2.1M2022-09-15: 2.5M2022-09-30: 3.1M2022-10-14: 3.2M2022-10-31: 2.8M2022-11-15: 2.4M2022-11-30: 2.6M2022-12-15: 2.4M2022-12-30: 2.5M2023-01-13: 2.7M2023-01-31: 2.3M2023-02-15: 2.5M2023-02-28: 2.6M2023-03-15: 2.2M2023-03-31: 2.1M2023-04-14: 2.2M2023-04-28: 2.0M2023-05-15: 5.7M2023-05-31: 5.5M2023-06-15: 8.7M2023-06-30: 7.4M2023-07-14: 7.6M2023-07-31: 7.2M2023-08-15: 7.1M2023-08-31: 6.2M
    the 31 Aug 2023 report24 earlier reportsnormal: 2.6M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 27 Sep 2023

    Privia Health had 5.9M shares sold short in the 15 Sep 2023 report, 2.4× the same report last year.

    This period
    5.9M (the 15 Sep 2023 report)
    Normal report (median of 24 earlier)
    2.7M
    Typical spread (median absolute deviation)
    477K
    How far from its usual level
    +4.6
    Same report last year
    2.5M
    History used
    854 days
    2022-09-15: 2.5M2022-09-30: 3.1M2022-10-14: 3.2M2022-10-31: 2.8M2022-11-15: 2.4M2022-11-30: 2.6M2022-12-15: 2.4M2022-12-30: 2.5M2023-01-13: 2.7M2023-01-31: 2.3M2023-02-15: 2.5M2023-02-28: 2.6M2023-03-15: 2.2M2023-03-31: 2.1M2023-04-14: 2.2M2023-04-28: 2.0M2023-05-15: 5.7M2023-05-31: 5.5M2023-06-15: 8.7M2023-06-30: 7.4M2023-07-14: 7.6M2023-07-31: 7.2M2023-08-15: 7.1M2023-08-31: 6.2M2023-09-15: 5.9M
    the 15 Sep 2023 report24 earlier reportsnormal: 2.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 12 Oct 2023

    Privia Health had 6.4M shares sold short in the 29 Sep 2023 report, 2.0× the same report last year.

    This period
    6.4M (the 29 Sep 2023 report)
    Normal report (median of 24 earlier)
    2.8M
    Typical spread (median absolute deviation)
    569K
    How far from its usual level
    +4.3
    Same report last year
    3.1M
    History used
    868 days
    2022-09-30: 3.1M2022-10-14: 3.2M2022-10-31: 2.8M2022-11-15: 2.4M2022-11-30: 2.6M2022-12-15: 2.4M2022-12-30: 2.5M2023-01-13: 2.7M2023-01-31: 2.3M2023-02-15: 2.5M2023-02-28: 2.6M2023-03-15: 2.2M2023-03-31: 2.1M2023-04-14: 2.2M2023-04-28: 2.0M2023-05-15: 5.7M2023-05-31: 5.5M2023-06-15: 8.7M2023-06-30: 7.4M2023-07-14: 7.6M2023-07-31: 7.2M2023-08-15: 7.1M2023-08-31: 6.2M2023-09-15: 5.9M2023-09-29: 6.4M
    the 29 Sep 2023 report24 earlier reportsnormal: 2.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 25 Oct 2023

    Privia Health had 6.1M shares sold short in the 13 Oct 2023 report, 1.9× the same report last year.

    This period
    6.1M (the 13 Oct 2023 report)
    Normal report (median of 24 earlier)
    2.8M
    Typical spread (median absolute deviation)
    592K
    How far from its usual level
    +3.8
    Same report last year
    3.2M
    History used
    882 days
    2022-10-14: 3.2M2022-10-31: 2.8M2022-11-15: 2.4M2022-11-30: 2.6M2022-12-15: 2.4M2022-12-30: 2.5M2023-01-13: 2.7M2023-01-31: 2.3M2023-02-15: 2.5M2023-02-28: 2.6M2023-03-15: 2.2M2023-03-31: 2.1M2023-04-14: 2.2M2023-04-28: 2.0M2023-05-15: 5.7M2023-05-31: 5.5M2023-06-15: 8.7M2023-06-30: 7.4M2023-07-14: 7.6M2023-07-31: 7.2M2023-08-15: 7.1M2023-08-31: 6.2M2023-09-15: 5.9M2023-09-29: 6.4M2023-10-13: 6.1M
    the 13 Oct 2023 report24 earlier reportsnormal: 2.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 10 Nov 2023

    Privia Health had 6.6M shares sold short in the 31 Oct 2023 report, 2.3× the same report last year.

    This period
    6.6M (the 31 Oct 2023 report)
    Normal report (median of 24 earlier)
    2.8M
    Typical spread (median absolute deviation)
    698K
    How far from its usual level
    +3.7
    Same report last year
    2.8M
    History used
    900 days
    2022-10-31: 2.8M2022-11-15: 2.4M2022-11-30: 2.6M2022-12-15: 2.4M2022-12-30: 2.5M2023-01-13: 2.7M2023-01-31: 2.3M2023-02-15: 2.5M2023-02-28: 2.6M2023-03-15: 2.2M2023-03-31: 2.1M2023-04-14: 2.2M2023-04-28: 2.0M2023-05-15: 5.7M2023-05-31: 5.5M2023-06-15: 8.7M2023-06-30: 7.4M2023-07-14: 7.6M2023-07-31: 7.2M2023-08-15: 7.1M2023-08-31: 6.2M2023-09-15: 5.9M2023-09-29: 6.4M2023-10-13: 6.1M2023-10-31: 6.6M
    the 31 Oct 2023 report24 earlier reportsnormal: 2.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

  26. 14 Aug 2023Institutional holdings change

    saw 61 13F filers open a new position in the quarter ended 30 Jun 2023, 2.0× the same quarter last year.

    Same quarter last year: 30; its normal quarter is 32.

    See the evidence
    This period
    61 (the quarter ended 30 Jun 2023)
    Normal quarter (median of 8 earlier)
    32
    Typical spread (median absolute deviation)
    4.5
    How far from its usual level
    +4.3
    Same quarter last year
    30
    History used
    730 days
    2021-06-30: 852021-09-30: 202021-12-31: 332022-03-31: 392022-06-30: 302022-09-30: 622022-12-31: 302023-03-31: 312023-06-30: 61
    the quarter ended 30 Jun 20238 earlier quartersnormal: 32

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  27. 10 Aug 2023Short interest and volume change

    had 7.2M shares sold short in the 31 Jul 2023 report, 3.0× the same report last year.

    Same report last year: 2.4M; its normal report is 2.5M.

    See the evidence
    This period
    7.2M (the 31 Jul 2023 report)
    Normal report (median of 24 earlier)
    2.5M
    Typical spread (median absolute deviation)
    299K
    How far from its usual level
    +10.6
    Same report last year
    2.4M
    History used
    808 days
    2022-07-29: 2.4M2022-08-15: 2.2M2022-08-31: 2.1M2022-09-15: 2.5M2022-09-30: 3.1M2022-10-14: 3.2M2022-10-31: 2.8M2022-11-15: 2.4M2022-11-30: 2.6M2022-12-15: 2.4M2022-12-30: 2.5M2023-01-13: 2.7M2023-01-31: 2.3M2023-02-15: 2.5M2023-02-28: 2.6M2023-03-15: 2.2M2023-03-31: 2.1M2023-04-14: 2.2M2023-04-28: 2.0M2023-05-15: 5.7M2023-05-31: 5.5M2023-06-15: 8.7M2023-06-30: 7.4M2023-07-14: 7.6M2023-07-31: 7.2M
    the 31 Jul 2023 report24 earlier reportsnormal: 2.5M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  28. 31 Jul 2023Filings record

    Director or officer change

  29. 26 Jul 2023Short interest and volume change

    had 7.6M shares sold short in the 14 Jul 2023 report, 3.8× the same report last year.

    Same report last year: 2.0M; its normal report is 2.5M.

    See the evidence
    This period
    7.6M (the 14 Jul 2023 report)
    Normal report (median of 24 earlier)
    2.5M
    Typical spread (median absolute deviation)
    261K
    How far from its usual level
    +13.3
    Same report last year
    2.0M
    History used
    791 days
    2022-07-15: 2.0M2022-07-29: 2.4M2022-08-15: 2.2M2022-08-31: 2.1M2022-09-15: 2.5M2022-09-30: 3.1M2022-10-14: 3.2M2022-10-31: 2.8M2022-11-15: 2.4M2022-11-30: 2.6M2022-12-15: 2.4M2022-12-30: 2.5M2023-01-13: 2.7M2023-01-31: 2.3M2023-02-15: 2.5M2023-02-28: 2.6M2023-03-15: 2.2M2023-03-31: 2.1M2023-04-14: 2.2M2023-04-28: 2.0M2023-05-15: 5.7M2023-05-31: 5.5M2023-06-15: 8.7M2023-06-30: 7.4M2023-07-14: 7.6M
    the 14 Jul 2023 report24 earlier reportsnormal: 2.5M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  30. 13 Jul 2023Short interest and volume change

    had 7.4M shares sold short in the 30 Jun 2023 report, 3.0× the same report last year.

    Same report last year: 2.5M; its normal report is 2.5M.

    See the evidence
    This period
    7.4M (the 30 Jun 2023 report)
    Normal report (median of 24 earlier)
    2.5M
    Typical spread (median absolute deviation)
    250K
    How far from its usual level
    +13.2
    Same report last year
    2.5M
    History used
    777 days
    2022-06-30: 2.5M2022-07-15: 2.0M2022-07-29: 2.4M2022-08-15: 2.2M2022-08-31: 2.1M2022-09-15: 2.5M2022-09-30: 3.1M2022-10-14: 3.2M2022-10-31: 2.8M2022-11-15: 2.4M2022-11-30: 2.6M2022-12-15: 2.4M2022-12-30: 2.5M2023-01-13: 2.7M2023-01-31: 2.3M2023-02-15: 2.5M2023-02-28: 2.6M2023-03-15: 2.2M2023-03-31: 2.1M2023-04-14: 2.2M2023-04-28: 2.0M2023-05-15: 5.7M2023-05-31: 5.5M2023-06-15: 8.7M2023-06-30: 7.4M
    the 30 Jun 2023 report24 earlier reportsnormal: 2.5M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  31. 29 Jun 2023Filings record

    Director or officer change

  32. 28 Jun 2023Short interest and volume change

    had 8.7M shares sold short in the 15 Jun 2023 report, 4.0× the same report last year.

    Same report last year: 2.2M; its normal report is 2.4M.

    See the evidence
    This period
    8.7M (the 15 Jun 2023 report)
    Normal report (median of 24 earlier)
    2.4M
    Typical spread (median absolute deviation)
    250K
    How far from its usual level
    +16.7
    Same report last year
    2.2M
    History used
    762 days
    2022-06-15: 2.2M2022-06-30: 2.5M2022-07-15: 2.0M2022-07-29: 2.4M2022-08-15: 2.2M2022-08-31: 2.1M2022-09-15: 2.5M2022-09-30: 3.1M2022-10-14: 3.2M2022-10-31: 2.8M2022-11-15: 2.4M2022-11-30: 2.6M2022-12-15: 2.4M2022-12-30: 2.5M2023-01-13: 2.7M2023-01-31: 2.3M2023-02-15: 2.5M2023-02-28: 2.6M2023-03-15: 2.2M2023-03-31: 2.1M2023-04-14: 2.2M2023-04-28: 2.0M2023-05-15: 5.7M2023-05-31: 5.5M2023-06-15: 8.7M
    the 15 Jun 2023 report24 earlier reportsnormal: 2.4M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  33. 10 Jun 2023Short interest and volume change

    had 5.5M shares sold short in the 31 May 2023 report, 2.5× the same report last year.

    Same report last year: 2.2M; its normal report is 2.4M.

    See the evidence
    This period
    5.5M (the 31 May 2023 report)
    Normal report (median of 24 earlier)
    2.4M
    Typical spread (median absolute deviation)
    221K
    How far from its usual level
    +9.4
    Same report last year
    2.2M
    History used
    747 days
    2022-05-31: 2.2M2022-06-15: 2.2M2022-06-30: 2.5M2022-07-15: 2.0M2022-07-29: 2.4M2022-08-15: 2.2M2022-08-31: 2.1M2022-09-15: 2.5M2022-09-30: 3.1M2022-10-14: 3.2M2022-10-31: 2.8M2022-11-15: 2.4M2022-11-30: 2.6M2022-12-15: 2.4M2022-12-30: 2.5M2023-01-13: 2.7M2023-01-31: 2.3M2023-02-15: 2.5M2023-02-28: 2.6M2023-03-15: 2.2M2023-03-31: 2.1M2023-04-14: 2.2M2023-04-28: 2.0M2023-05-15: 5.7M2023-05-31: 5.5M
    the 31 May 2023 report24 earlier reportsnormal: 2.4M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  34. 25 May 2023Short interest and volume change

    had 5.7M shares sold short in the 15 May 2023 report, 2.8× the same report last year.

    Same report last year: 2.0M; its normal report is 2.4M.

    See the evidence
    This period
    5.7M (the 15 May 2023 report)
    Normal report (median of 24 earlier)
    2.4M
    Typical spread (median absolute deviation)
    205K
    How far from its usual level
    +11.0
    Same report last year
    2.0M
    History used
    731 days
    2022-05-13: 2.0M2022-05-31: 2.2M2022-06-15: 2.2M2022-06-30: 2.5M2022-07-15: 2.0M2022-07-29: 2.4M2022-08-15: 2.2M2022-08-31: 2.1M2022-09-15: 2.5M2022-09-30: 3.1M2022-10-14: 3.2M2022-10-31: 2.8M2022-11-15: 2.4M2022-11-30: 2.6M2022-12-15: 2.4M2022-12-30: 2.5M2023-01-13: 2.7M2023-01-31: 2.3M2023-02-15: 2.5M2023-02-28: 2.6M2023-03-15: 2.2M2023-03-31: 2.1M2023-04-14: 2.2M2023-04-28: 2.0M2023-05-15: 5.7M
    the 15 May 2023 report24 earlier reportsnormal: 2.4M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  35. 12 Apr 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  36. 12 Apr 2023Filings record

    Director or officer change

  37. 21 Mar 2023Filings record

    A major agreement ended

  38. 15 Nov 2022Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  39. 15 Nov 2022Filings record

    Director or officer change

  40. 16 Aug 2022Financials change

    reported revenue of $335.5M for the quarter ended 30 Jun 2022, 1.5× the same quarter last year.

    Same quarter last year: $225.8M; its normal quarter is $219.7M.

    See the evidence
    This period
    $335.5M (the quarter ended 30 Jun 2022)
    Normal quarter (median of 8 earlier)
    $219.7M
    Typical spread (median absolute deviation)
    $22.2M
    How far from its usual level
    +3.5
    Same quarter last year
    $225.8M
    History used
    821 days
    2020-06-30: $183.3M2020-09-30: $207.2M2020-12-31: $213.7M2021-03-31: $213.6M2021-06-30: $225.8M2021-09-30: $251.5M2021-12-31: $275.3M2022-03-31: $313.8M2022-06-30: $335.5M
    the quarter ended 30 Jun 20228 earlier quartersnormal: $219.7M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

Showing the newest 40 of 59 entries; narrow the window or the kind of data to see older ones.

Not listed: 261 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001759655
Ticker
PRVA
Domain
priviahealth.com
Employer name
privia health, Privia Medical Group, Arizona (2 unverified)
Fein
86-0783428 (1 unverified)
Hq location
VA|ARLINGTON|22203 (1 unverified)
Lobbying client
privia medical group north texas
Name
BASS Privia Management Company of California, LLC, Berdayes Medical Association, PLLC, CMG ACO, LLC, Complete MD Solutions, LLC and 70 more
  • DOL H-1B labor condition applications and PERM certifications5 data points1 Jul 2026 to 1 Jul 2026
  • Federal lobbying disclosures (LDA)2 records, 48 data points1 Apr 2020 to 31 Mar 2024
  • SEC Form 13F institutional holdings2 records, 198 data points30 Jun 2021 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)79 records13 Feb 2019 to 5 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)333 data points31 Dec 2018 to 30 Oct 2026
  • SEC Form 4 insider transactions210 records, 528 data points5 May 2021 to 13 Jul 2026
  • FINRA short interest (twice monthly)392 data points14 May 2021 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)2798 data points29 Apr 2021 to 20 Nov 2026